Joint Formulary & PAD

Drospirenone with estetrol - Contraception

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important

Not recommended for new initiations. Existing patients may remain on this brand.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Drospirenone with estetrol
Indication :
Contraception
Group Name :
Keywords :
combined hormonal contraceptive, CHC
Brand Names Include :
Drovelis
Important Information :

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Drospirenone with estetrol is used to treat.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.